![Stephen M. Condon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen M. Condon
No más puestos en curso
Historial de carrera de Stephen M. Condon
Antiguos cargos conocidos de Stephen M. Condon.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Rhone Poulenc Rorer
![]() Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 01/01/2000 | 01/01/2000 |
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - | - |
TETRALOGIC PHARMACEUTICALS CORPORATION | Director Técnico/Científico/I+D | 01/05/2004 | - |
Corporate Officer/Principal | 01/05/2004 | - |
Formación de Stephen M. Condon.
University of Pennsylvania | Doctorate Degree |
University of Massachusetts | Undergraduate Degree |
University of Georgia | Graduate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Francia | 2 |
Operativa
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 3 |
Process Industries | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
Empresas privadas | 2 |
---|---|
Shire ViroPharma, Inc.
![]() Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Rhone Poulenc Rorer
![]() Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |
- Bolsa de valores
- Insiders
- Stephen M. Condon
- Experiencia